☰

Gregory A. Light - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 
Area:
schizophrenia, MMN, PPI, P50
Website:
http://psychiatry.ucsd.edu/faculty/GLight.html
Tree Info Grants Similar researchers PubMed Report error

195/239 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Abplanalp SJ, Braff DL, Light GA, Joshi YB, Nuechterlein KH, Green MF. Clarifying directional dependence among measures of early auditory processing and cognition in schizophrenia: leveraging Gaussian graphical models and Bayesian networks. Psychological Medicine. 1-10. PMID 38287656 DOI: 10.1017/S0033291724000023  0.684
2023 Joshi Y, Swerdlow N, Light G. Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh. The American Journal of Psychiatry. 180: 841-842. PMID 37908092 DOI: 10.1176/appi.ajp.20230419r  0.437
2023 Joshi YB, Molina JL, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, ... ... Light GA, et al. Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden. The American Journal of Psychiatry. appiajp20220649. PMID 37038743 DOI: 10.1176/appi.ajp.20220649  0.72
2022 Duncan E, Roach BJ, Massa N, Hamilton HK, Bachman PM, Belger A, Carrion RE, Johannesen JK, Light GA, Niznikiewicz MA, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort. Schizophrenia Research. 248: 89-97. PMID 35994912 DOI: 10.1016/j.schres.2022.07.019  0.394
2022 Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF. Understanding Connections and Boundaries Between Positive Symptoms, Negative Symptoms, and Role Functioning Among Individuals With Schizophrenia: A Network Psychometric Approach. Jama Psychiatry. PMID 35976655 DOI: 10.1001/jamapsychiatry.2022.2386  0.688
2022 Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, ... ... Light GA, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. PMID 35396580 DOI: 10.1038/s41586-022-04434-5  0.705
2022 Koshiyama D, Miyakoshi M, Tanaka-Koshiyama K, Sprock J, Light GA. High-power gamma-related delta phase alteration in schizophrenia patients at rest. Psychiatry and Clinical Neurosciences. PMID 35037330 DOI: 10.1111/pcn.13331  0.338
2021 Clayson PE, Molina JL, Joshi YB, Thomas ML, Sprock J, Nungaray J, Swerdlow NR, Light GA. Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia. Psychiatry Research. 305: 114239. PMID 34673326 DOI: 10.1016/j.psychres.2021.114239  0.402
2021 Molina JL, Joshi YB, Nungaray JA, Thomas ML, Sprock J, Clayson PE, Sanchez VA, Attarha M, Biagianti B, Swerdlow NR, Light GA. Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training. Schizophrenia Research. 236: 135-141. PMID 34500174 DOI: 10.1016/j.schres.2021.07.033  0.388
2021 Clayson PE, Joshi YB, Thomas ML, Tarasenko M, Bismark A, Sprock J, Nungaray J, Cardoso L, Wynn JK, Swerdlow NR, Light GA. The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia. Schizophrenia Research. PMID 34187732 DOI: 10.1016/j.schres.2021.06.022  0.413
2021 Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, ... ... Light GA, et al. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia. The American Journal of Psychiatry. appiajp202020081212. PMID 33985348 DOI: 10.1176/appi.ajp.2020.20081212  0.725
2021 Thomas ML, Duffy JR, Swerdlow N, Light GA, Brown GG. Detecting the Inverted-U in fMRI Studies of Schizophrenia: A Comparison of Three Analysis Methods. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 33949299 DOI: 10.1017/S1355617721000424  0.389
2021 Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Vinogradov S, Molina JL, Light GA. Auditory discrimination and frequency modulation learning in schizophrenia patients: amphetamine within-subject dose response and time course. Psychological Medicine. 1-9. PMID 33849683 DOI: 10.1017/S0033291721001239  0.455
2021 Koshiyama D, Miyakoshi M, Tanaka-Koshiyama K, Joshi YB, Sprock J, Braff DL, Light GA. Abnormal phase discontinuity of alpha- and theta-frequency oscillations in schizophrenia. Schizophrenia Research. 231: 73-81. PMID 33780847 DOI: 10.1016/j.schres.2021.03.007  0.727
2021 Foss-Feig JH, Guillory SB, Roach BJ, Velthorst E, Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington JM, Cadenhead KS, Cannon TD, et al. Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study. Frontiers in Psychiatry. 12: 591127. PMID 33633603 DOI: 10.3389/fpsyt.2021.591127  0.316
2021 Koshiyama D, Miyakoshi M, Thomas ML, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia. Schizophrenia Research. 228: 280-287. PMID 33493776 DOI: 10.1016/j.schres.2020.12.042  0.753
2021 Koshiyamaf D, Miyakoshi M, Joshi YB, Nakanishi M, Tanaka-Koshiyama K, Sprock J, Light GA. Source Decomposition of the Frontocentral Auditory Steady-State Gamma Band Response in Schizophrenia Patients and Healthy Subjects. Psychiatry and Clinical Neurosciences. PMID 33470494 DOI: 10.1111/pcn.13201  0.367
2021 Koshiyama D, Miyakoshi M, Joshi YB, Nakanishi M, Tanaka-Koshiyama K, Sprock J, Light GA. Sources of the frontocentral mismatch negativity and P3a responses in schizophrenia patients and healthy comparison subjects. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 33453303 DOI: 10.1016/j.ijpsycho.2021.01.005  0.516
2020 Ahmed S, Lepock JR, Mizrahi R, Bagby RM, Gerritsen CJ, Korostil M, Light GA, Kiang M. Decreased Gamma Auditory Steady-State Response Is Associated With Impaired Real-World Functioning in Unmedicated Patients at Clinical High Risk for Psychosis. Clinical Eeg and Neuroscience. 1550059420982706. PMID 33356513 DOI: 10.1177/1550059420982706  0.449
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Joyce Sprock, Braff DL, Swerdlow NR, Light GA. Neural network dynamics underlying gamma synchronization deficits in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110224. PMID 33340619 DOI: 10.1016/j.pnpbp.2020.110224  0.73
2020 Koshiyama D, Miyakoshi M, Tanaka-Koshiyama K, Joshi YB, Molina JL, Sprock J, Braff DL, Light GA. Neurophysiologic Characterization of Resting State Connectivity Abnormalities in Schizophrenia Patients. Frontiers in Psychiatry. 11: 608154. PMID 33329160 DOI: 10.3389/fpsyt.2020.608154  0.708
2020 Molina JL, Thomas ML, Joshi YB, Hochberger WC, Koshiyama D, Nungaray JA, Cardoso L, Sprock J, Braff DL, Swerdlow NR, Light GA. Gamma oscillations predict pro-cognitive and clinical response to auditory-based cognitive training in schizophrenia. Translational Psychiatry. 10: 405. PMID 33230190 DOI: 10.1038/s41398-020-01089-6  0.689
2020 Desai A, Benner L, Wu R, Gertsik L, Maruff P, Light GA, Uz T, Marek GJ, Zhu T. Phase 1 randomized study on the safety, tolerability, and pharmacodynamic cognitive and electrophysiological effects of a dopamine D receptor positive allosteric modulator in patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33203954 DOI: 10.1038/s41386-020-00908-0  0.402
2020 Greenwood TA, Swerdlow NR, Sprock J, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Silverman JM, Stone WS, Sugar CA, et al. Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia. Schizophrenia Research. PMID 33189519 DOI: 10.1016/j.schres.2020.11.003  0.751
2020 Tanaka-Koshiyama K, Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Sprock J, Braff DL, Light GA. Abnormal Spontaneous Gamma Power Is Associated With Verbal Learning and Memory Dysfunction in Schizophrenia. Frontiers in Psychiatry. 11: 832. PMID 33110410 DOI: 10.3389/fpsyt.2020.00832  0.744
2020 Cadenhead KS, Duncan E, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bauchman P, Belger A, ... ... Light G, et al. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm. Frontiers in Psychiatry. 11: 833. PMID 33005152 DOI: 10.3389/Fpsyt.2020.00833  0.345
2020 Swerdlow NR, Bhakta S, Talledo J, Kotz J, Roberts BZ, Clifford RE, Thomas M, Joshi Y, Molina JL, Light GA. Memantine effects on auditory discrimination and training in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32961542 DOI: 10.1038/s41386-020-00865-8  0.466
2020 Koshiyama D, Thomas ML, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia. Schizophrenia Bulletin. PMID 32856089 DOI: 10.1093/Schbul/Sbaa116  0.766
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Abnormal Effective Connectivity Underlying Auditory Mismatch Negativity Impairments in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32830097 DOI: 10.1016/J.Bpsc.2020.05.011  0.778
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. A distributed frontotemporal network underlies gamma-band synchronization impairments in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32829382 DOI: 10.1038/S41386-020-00806-5  0.762
2020 Fryer SL, Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. Journal of Abnormal Psychology. 129: 599-611. PMID 32757603 DOI: 10.1037/abn0000513  0.379
2020 Lee J, Green MF, Nuechterlein KH, Swerdlow NR, Greenwood TA, Hellemann GS, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study. Plos One. 15: e0232855. PMID 32401791 DOI: 10.1371/Journal.Pone.0232855  0.734
2020 Molina JL, Voytek B, Thomas ML, Joshi YB, Bhakta SG, Talledo JA, Swerdlow NR, Light GA. Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32340927 DOI: 10.1016/J.Bpsc.2020.02.004  0.575
2020 Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Kenney JG, Light G, Niznikiewicz M, Addington J, Bearden CE, Owens EM, Cadenhead KS, Cannon TD, et al. Stability of mismatch negativity event-related potentials in a multisite study. International Journal of Methods in Psychiatric Research. e1819. PMID 32232944 DOI: 10.1002/Mpr.1819  0.443
2020 Seech TR, Funke ME, Sharp RF, Light GA, Blacker KJ. Impaired Sensory Processing During Low-Oxygen Exposure: A Noninvasive Approach to Detecting Changes in Cognitive States. Frontiers in Psychiatry. 11: 12. PMID 32082202 DOI: 10.3389/Fpsyt.2020.00012  0.338
2020 Tanaka-Koshiyama K, Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Sprock J, Braff DL, Light GA. Abnormal Spontaneous Gamma Power Is Associated With Verbal Learning and Memory Dysfunction in Schizophrenia Frontiers in Psychiatry. 11. DOI: 10.3389/Fpsyt.2020.00832  0.689
2020 Koshiyama D, Miyakoshi M, Thomas ML, Joshi YB, Molina JL, Tanaka-Koshiyama K, Nungaray JA, Sprock J, Braff DL, Swerdlow NR, Light GA. Auditory-Based Cognitive Training Drives Short- and Long-Term Plasticity in Cortical Networks in Schizophrenia Schizophrenia Bulletin Open. 1. DOI: 10.1093/schizbullopen/sgaa065  0.405
2020 Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Johannesen J, Light G, Niznikiewicz M, Addington J, Bearden C, Cadenhead K, Cornblatt B, McGlashan T, Perkins D, Seidman L, et al. O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY Schizophrenia Bulletin. 46: S24-S25. DOI: 10.1093/Schbul/Sbaa028.056  0.431
2020 Light GA, Joshi YB, Molina JL, Bhakta SG, Nungaray JA, Cardoso L, Kotz JE, Thomas ML, Swerdlow NR. Neurophysiological biomarkers for schizophrenia therapeutics Biomarkers in Neuropsychiatry. 2: 100012. DOI: 10.1016/j.bionps.2020.100012  0.53
2019 Hochberger WC, Thomas ML, Joshi YB, Molina J, Treichler EBH, Nungaray J, Cardoso L, Sprock J, Swerdlow N, Light GA. Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients. Schizophrenia Research. PMID 31759809 DOI: 10.1016/J.Schres.2019.11.015  0.478
2019 Hochberger WC, Thomas ML, Joshi YB, Swerdlow NR, Braff DL, Gur RE, Gur RC, Light GA. Deviation from expected cognitive ability is a core cognitive feature of schizophrenia related to neurophysiologic, clinical and psychosocial functioning. Schizophrenia Research. PMID 31744751 DOI: 10.1016/J.Schres.2019.10.011  0.483
2019 Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, et al. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. Jama Psychiatry. PMID 31596458 DOI: 10.1001/Jamapsychiatry.2019.2850  0.786
2019 Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Lavadia M, Light GA. Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31445502 DOI: 10.1038/S41386-019-0495-4  0.568
2019 Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrion RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, et al. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. Jama Psychiatry. PMID 31389974 DOI: 10.1001/Jamapsychiatry.2019.2135  0.516
2019 Perez VB, Miyakoshi M, Makeig SD, Light GA. Mismatch negativity reveals plasticity in cortical dynamics after 1-hour of auditory training exercises. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 31176741 DOI: 10.1016/J.Ijpsycho.2019.06.003  0.443
2019 Lainscsek C, Sampson AL, Kim R, Thomas ML, Man K, Lainscsek X, Swerdlow NR, Braff DL, Sejnowski TJ, Light GA. Nonlinear dynamics underlying sensory processing dysfunction in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 116: 3847-3852. PMID 30808768 DOI: 10.1073/Pnas.1810572116  0.701
2019 Joshi YB, Thomas ML, Hochberger WC, Bismark AW, Treichler EBH, Molina J, Nungaray J, Cardoso L, Sprock J, Swerdlow NR, Light GA. Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophrenia Research. PMID 30738698 DOI: 10.1016/J.Schres.2019.01.016  0.428
2019 Lepock JR, Ahmed S, Mizrahi R, Gerritsen CJ, Maheandiran M, Drvaric L, Bagby RM, Korostil M, Light GA, Kiang M. Relationships between cognitive event-related brain potential measures in patients at clinical high risk for psychosis. Schizophrenia Research. PMID 30683525 DOI: 10.1016/J.Schres.2019.01.014  0.466
2019 Treichler EBH, Thomas ML, Bismark AW, Hochberger WC, Tarasenko M, Nungaray J, Cardoso L, Joshi YB, Zhang W, Sprock J, Swerdlow N, Cohen AN, Light GA. Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia. Schizophrenia Research. PMID 30660574 DOI: 10.1016/J.Schres.2018.12.034  0.39
2018 Hochberger WC, Joshi YB, Zhang W, Thomas ML, Braff DL, Swerdlow NR, Light GA. Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 30586570 DOI: 10.1016/J.Ijpsycho.2018.12.014  0.765
2018 Joshi YB, Light GA. Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia. Frontiers in Psychiatry. 9: 554. PMID 30510520 DOI: 10.3389/Fpsyt.2018.00554  0.489
2018 Hochberger WC, Joshi YB, Thomas ML, Zhang W, Bismark AW, Treichler EBH, Tarasenko M, Nungaray J, Sprock J, Cardoso L, Swerdlow N, Light GA. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30377381 DOI: 10.1038/S41386-018-0256-9  0.69
2018 Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W, Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, ... Light GA, et al. Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophrenia Research. PMID 30055883 DOI: 10.1016/J.Schres.2018.07.025  0.718
2018 Thomas ML, Treichler EBH, Bismark A, Shiluk AL, Tarasenko M, Zhang W, Joshi YB, Sprock J, Cardoso L, Tiernan K, Light GA. Computerized cognitive training is associated with improved psychosocial treatment engagement in schizophrenia. Schizophrenia Research. PMID 29929773 DOI: 10.1016/J.Schres.2018.06.024  0.418
2018 Bismark AW, Thomas ML, Tarasenko M, Shiluk AL, Rackelmann SY, Young JW, Light GA. Reverse translated and gold standard continuous performance tests predict global cognitive performance in schizophrenia. Translational Psychiatry. 8: 80. PMID 29643355 DOI: 10.1038/S41398-018-0127-5  0.418
2018 Swerdlow NR, Bhakta SG, Light GA. Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge. Schizophrenia Research. PMID 29627173 DOI: 10.1016/J.Schres.2018.03.037  0.477
2018 Swerdlow NR, Light GA. Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates. Schizophrenia Research. PMID 29525460 DOI: 10.1016/J.Schres.2018.02.042  0.57
2018 Young JW, Light GA. Cross-Species Neurophysiological Biomarkers of Attentional Dysfunction in Schizophrenia: Bridging the Translational Gap. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 43: 230-231. PMID 29192660 DOI: 10.1038/Npp.2017.218  0.532
2018 Foss-Feig J, Velthorst E, Guillory S, Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Addington J, Cadenhead K, Cannon T, et al. F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER Schizophrenia Bulletin. 44: S266-S266. DOI: 10.1093/Schbul/Sby017.649  0.372
2018 Joshi Y, Thomas M, Bismark A, Treichler E, Tarasenko M, Cardoso L, Nungaray J, Molina J, Tiernan K, Swerdlow N, Light G. T207. Schizophrenia Patients in Community-Based Residential Care are Able to Benefit From Auditory-Based Targeted Cognitive Training: Improvement in Cognitive Measures and Positive Symptoms Biological Psychiatry. 83: S208-S209. DOI: 10.1016/J.Biopsych.2018.02.544  0.474
2018 Greenwood T, Lazzeroni L, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light G, Nuechterlein K, Olincy A, Radant A, Seidman L, Siever L, Silverman J, Stone W, et al. S209. Genome-Wide Association of Endophenotypes for Schizophrenia From the Consortium On the Genetics of Schizophrenia (COGS) Study Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1101  0.772
2018 Swerdlow N, Bhakta S, Talledo J, Franz D, Rana B, Light G. 72. One Pill Can Enhance Auditory Information Processing and Learning in Schizophrenia Patients: Should We Rethink the Way We’re Approaching Therapeutic Development for Schizophrenia? Biological Psychiatry. 83: S29-S30. DOI: 10.1016/J.Biopsych.2018.02.089  0.598
2017 Swerdlow NR, Bhakta SG, Talledo JA, Franz DM, Hughes EL, Rana BK, Light GA. Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29154367 DOI: 10.1038/Npp.2017.285  0.587
2017 Bhakta SG, Light GA, Talledo JA, Balvaneda B, Hughes E, Alvarez A, Rana BK, Young JW, Swerdlow NR. Tolcapone-enhanced neurocognition in healthy adults: neural basis and predictors. The International Journal of Neuropsychopharmacology. PMID 29020372 DOI: 10.1093/Ijnp/Pyx074  0.439
2017 Joshi YB, Breitenstein B, Tarasenko M, Thomas ML, Chang WL, Sprock J, Sharp RF, Light GA. Mismatch negativity impairment is associated with deficits in identifying real-world environmental sounds in schizophrenia. Schizophrenia Research. PMID 28927552 DOI: 10.1016/J.Schres.2017.05.020  0.593
2017 Bismark AW, Thomas ML, Tarasenko M, Shiluk AL, Rackelmann SY, Young JW, Light GA. Relationship between effortful motivation and neurocognition in schizophrenia. Schizophrenia Research. PMID 28673753 DOI: 10.1016/J.Schres.2017.06.042  0.435
2017 Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension. Schizophrenia Research. PMID 28549722 DOI: 10.1016/J.Schres.2017.05.013  0.757
2017 Light GA, Zhang W, Joshi YB, Bhakta S, Talledo JA, Swerdlow NR. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28425497 DOI: 10.1038/Npp.2017.81  0.496
2017 Thomas ML, Patt VM, Bismark A, Sprock J, Tarasenko M, Light GA, Brown GG. Evidence of Systematic Attenuation in the Measurement of Cognitive Deficits in Schizophrenia. Journal of Abnormal Psychology. PMID 28277736 DOI: 10.1037/Abn0000256  0.485
2017 Perez VB, Tarasenko M, Miyakoshi M, Pianka ST, Makeig SD, Braff DL, Swerdlow NR, Light GA. Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28139679 DOI: 10.1038/Npp.2017.25  0.67
2017 Tarasenko M, Zhang W, Shiluk A, Rackelmann S, Taylor A, Cardoso L, Bismark A, Thomas M, Sprock J, Tiernan K, Kauffman C, Swerdlow N, Light G. SA62. The Auditory Brainstem Response to Complex Sounds (cABR) Indexes Cognitive Network Function in Schizophrenia Schizophrenia Bulletin. 43: S135-S135. DOI: 10.1093/Schbul/Sbx023.061  0.402
2017 Wirth P, Shiluk A, Rackelmann S, Zhang W, Bismark A, Sprock J, Tarasenko M, Young J, Light G, Brown GG, Thomas M. SA34. Schizophrenia Patients May Invest Suboptimal Effort due to Poor Performance Insight Schizophrenia Bulletin. 43: S125-S125. DOI: 10.1093/Schbul/Sbx023.033  0.607
2017 Swerdlow N, Bhakta S, Thomas M, Joshi Y, Zhang W, Talledo J, Light G. 124. Experimental Medicine Approaches to Leveraging Auditory Information Processing Neuroplasticity Toward Therapeutic Development in Schizophrenia Schizophrenia Bulletin. 43: S69-S69. DOI: 10.1093/Schbul/Sbx021.182  0.535
2017 Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Roach B, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, et al. 80. Auditory Target Processing Deficits in Individuals at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S45-S45. DOI: 10.1093/Schbul/Sbx021.119  0.351
2017 Swerdlow N, Bhakta S, Thomas M, Joshi Y, Zhang W, Talledo J, Light G. 430. Leveraging Auditory Information Processing Neuroplasticity towards Therapeutic Development in Schizophrenia Biological Psychiatry. 81: S175-S176. DOI: 10.1016/J.Biopsych.2017.02.914  0.565
2016 Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, ... ... Light GA, et al. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. Jama Psychiatry. PMID 27926742 DOI: 10.1001/Jamapsychiatry.2016.2980  0.76
2016 Young JW, Bismark AW, Sun Y, Zhang W, McIlwain M, Grootendorst I, Light GA. Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27917869 DOI: 10.1038/Npp.2016.268  0.687
2016 Swerdlow NR, Tarasenko M, Bhakta SG, Talledo J, Alvarez AI, Hughes EL, Rana B, Vinogradov S, Light GA. Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients. Schizophrenia Bulletin. PMID 27798224 DOI: 10.1093/Schbul/Sbw148  0.535
2016 Swerdlow NR, Light GA. Animal Models of Deficient Sensorimotor Gating in Schizophrenia: Are They Still Relevant? Current Topics in Behavioral Neurosciences. PMID 27311762 DOI: 10.1007/7854_2015_5012  0.59
2016 Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, et al. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophrenia Research. PMID 27132484 DOI: 10.1016/J.Schres.2016.04.011  0.753
2016 Bhakta SG, Chou HH, Rana B, Talledo JA, Balvaneda B, Gaddis L, Light GA, Swerdlow NR. Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy. Psychopharmacology. PMID 27076209 DOI: 10.1007/S00213-016-4291-0  0.327
2016 Tarasenko M, Perez VB, Pianka ST, Vinogradov S, Braff DL, Swerdlow NR, Light GA. Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia. Schizophrenia Research. PMID 26851143 DOI: 10.1016/J.Schres.2016.01.019  0.666
2016 Kaufmann CN, Light GA, Martin AS, Daly R, Palmer BW, Jeste DV. Association between Mismatch Negativity and Psychopathology, Cognitive Impairment, and Health Status in Patients with Schizophrenia and Comparable Healthy Subjects The American Journal of Geriatric Psychiatry. 24: S75-S76. DOI: 10.1016/J.Jagp.2016.01.074  0.555
2015 Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophrenia Research. PMID 26597662 DOI: 10.1016/J.Schres.2015.11.008  0.745
2015 Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. The American Journal of Psychiatry. appiajp201515050605. PMID 26441157 DOI: 10.1176/Appi.Ajp.2015.15050605  0.716
2015 Swerdlow NR, Bhakta S, Chou HH, Talledo JA, Balvaneda B, Light GA. Memantine Effects on Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26062785 DOI: 10.1038/Npp.2015.162  0.454
2015 Young JW, Kamenski ME, Higa KK, Light GA, Geyer MA, Zhou X. GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25907107 DOI: 10.1038/Npp.2015.120  0.452
2015 Light GA, Swerdlow NR. Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. Annals of the New York Academy of Sciences. 1344: 105-19. PMID 25752648 DOI: 10.1111/Nyas.12730  0.468
2015 Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 38-46. PMID 25749017 DOI: 10.1016/J.Schres.2015.01.017  0.783
2015 Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, et al. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophrenia Research. 163: 73-9. PMID 25682549 DOI: 10.1016/J.Schres.2015.01.027  0.774
2015 Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, et al. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophrenia Research. 163: 47-52. PMID 25553977 DOI: 10.1016/J.Schres.2014.12.016  0.795
2015 Light GA, Makeig S. Electroencephalographic biomarkers of psychosis: present and future. Biological Psychiatry. 77: 87-9. PMID 25524305 DOI: 10.1016/J.Biopsych.2014.11.002  0.405
2015 Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, et al. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 32-7. PMID 25497440 DOI: 10.1016/J.Schres.2014.10.029  0.711
2015 Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, et al. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophrenia Research. 163: 63-72. PMID 25449710 DOI: 10.1016/J.Schres.2014.09.042  0.733
2015 Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophrenia Research. 163: 17-23. PMID 25432636 DOI: 10.1016/J.Schres.2014.10.049  0.744
2015 Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, ... ... Light G, et al. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophrenia Research. 163: 53-62. PMID 25306203 DOI: 10.1016/J.Schres.2014.09.024  0.748
2015 Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, et al. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophrenia Research. 163: 24-31. PMID 25248939 DOI: 10.1016/J.Schres.2014.08.014  0.764
2014 Rissling AJ, Miyakoshi M, Sugar CA, Braff DL, Makeig S, Light GA. Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia. Neuroimage. Clinical. 6: 424-37. PMID 25379456 DOI: 10.1016/J.Nicl.2014.09.006  0.699
2014 Tarasenko MA, Swerdlow NR, Makeig S, Braff DL, Light GA. The auditory brain-stem response to complex sounds: a potential biomarker for guiding treatment of psychosis. Frontiers in Psychiatry. 5: 142. PMID 25352811 DOI: 10.3389/Fpsyt.2014.00142  0.702
2014 Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, et al. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Research. 219: 67-71. PMID 24913833 DOI: 10.1016/J.Psychres.2014.05.035  0.737
2014 Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophrenia Bulletin. 40: 1404-11. PMID 24903414 DOI: 10.1093/Schbul/Sbu064  0.745
2014 Light GA, Swerdlow NR. Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle. Current Topics in Behavioral Neurosciences. 21: 293-314. PMID 24850080 DOI: 10.1007/7854_2014_316  0.498
2014 Mano QR, Brown GG, Mirzakhanian H, Bolden K, Cadenhead KS, Light GA. Not all distraction is bad: working memory vulnerability to implicit socioemotional distraction correlates with negative symptoms and functional impairment in psychosis. Schizophrenia Research and Treatment. 2014: 320948. PMID 24724026 DOI: 10.1155/2014/320948  0.355
2014 Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, et al. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? Plos One. 9: e88379. PMID 24523888 DOI: 10.1371/Journal.Pone.0088379  0.766
2014 Swerdlow NR, Light GA, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Ray A, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophrenia Research. 152: 503-12. PMID 24405980 DOI: 10.1016/J.Schres.2013.12.004  0.799
2014 Perez VB, Swerdlow NR, Braff DL, Näätänen R, Light GA. Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses. Biomarkers in Medicine. 8: 9-14. PMID 24325220 DOI: 10.2217/Bmm.13.133  0.672
2013 Young JW, Geyer MA, Rissling AJ, Sharp RF, Eyler LT, Asgaard GL, Light GA. Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice. Translational Psychiatry. 3: e324. PMID 24217494 DOI: 10.1038/Tp.2013.82  0.47
2013 Swerdlow NR, Light GA, Trim RS, Breier MR, Hines SR, Powell SB. Forebrain gene expression predicts deficits in sensorimotor gating after isolation rearing in male rats. Behavioural Brain Research. 257: 118-28. PMID 24076151 DOI: 10.1016/J.Bbr.2013.09.005  0.331
2013 Light GA, Näätänen R. Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders. Proceedings of the National Academy of Sciences of the United States of America. 110: 15175-6. PMID 23995447 DOI: 10.1073/Pnas.1313287110  0.476
2013 Swerdlow NR, Powell SB, Breier MR, Hines SR, Light GA. Coupling of gene expression in medial prefrontal cortex and nucleus accumbens after neonatal ventral hippocampal lesions accompanies deficits in sensorimotor gating and auditory processing in rats. Neuropharmacology. 75: 38-46. PMID 23810830 DOI: 10.1016/J.Neuropharm.2013.06.003  0.429
2013 Cadenhead KS, Addington J, Cannon TD, Cornblatt BA, de la Fuente-Sandoval C, Mathalon DH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bachman P, Belger A, Carrión RE, Donkers FC, ... ... Light G, et al. Between-site reliability of startle prepulse inhibition across two early psychosis consortia. Neuroreport. 24: 626-30. PMID 23799460 DOI: 10.1097/Wnr.0B013E3283637845  0.304
2013 Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, ... ... Light GA, et al. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 170: 521-32. PMID 23511790 DOI: 10.1176/Appi.Ajp.2012.12020186  0.725
2013 Rissling AJ, Park SH, Young JW, Rissling MB, Sugar CA, Sprock J, Mathias DJ, Pela M, Sharp RF, Braff DL, Light GA. Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls. Schizophrenia Research. 146: 326-35. PMID 23490760 DOI: 10.1016/J.Schres.2013.01.035  0.735
2013 Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, et al. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biological Psychiatry. 73: 976-84. PMID 23395246 DOI: 10.1016/J.Biopsych.2012.12.021  0.757
2013 Takahashi H, Rissling AJ, Pascual-Marqui R, Kirihara K, Pela M, Sprock J, Braff DL, Light GA. Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses. Neuroimage. 66: 594-603. PMID 23085112 DOI: 10.1016/J.Neuroimage.2012.09.074  0.755
2013 Rissling A, Miyakoshi M, Malaguti R, Sugar C, Braff D, Makeig S, Light G. Deconstructing the auditory sensory discrimination network in schizophrenia: clinical, cognitive, and functional correlates F1000research. 4. DOI: 10.7490/F1000Research.1093764.1  0.743
2012 Light GA, Swerdlow NR, Rissling AJ, Radant A, Sugar CA, Sprock J, Pela M, Geyer MA, Braff DL. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. Plos One. 7: e39434. PMID 22802938 DOI: 10.1371/Journal.Pone.0039434  0.782
2012 Swerdlow NR, Shilling PD, Breier M, Trim RS, Light GA, Marie RS. Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. Psychopharmacology. 224: 349-62. PMID 22700037 DOI: 10.1007/S00213-012-2758-1  0.419
2012 Rissling AJ, Braff DL, Swerdlow NR, Hellemann G, Rassovsky Y, Sprock J, Pela M, Light GA. Disentangling early sensory information processing deficits in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 123: 1942-9. PMID 22608970 DOI: 10.1016/J.Clinph.2012.02.079  0.796
2012 Swerdlow NR, Light GA, Breier MR, Shoemaker JM, Saint Marie RL, Neary AC, Geyer MA, Stevens KE, Powell SB. Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats. Developmental Neuroscience. 34: 240-9. PMID 22572564 DOI: 10.1159/000336841  0.483
2012 Kirihara K, Rissling AJ, Swerdlow NR, Braff DL, Light GA. Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biological Psychiatry. 71: 873-80. PMID 22361076 DOI: 10.1016/J.Biopsych.2012.01.016  0.779
2012 Thorp SR, Sones HM, Glorioso D, Thompson W, Light GA, Golshan S, Jeste DV. Older patients with schizophrenia: does military veteran status matter? The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 248-56. PMID 22354115 DOI: 10.1097/Jgp.0B013E3182096Ae5  0.504
2012 Greenwood TA, Light GA, Swerdlow NR, Radant AD, Braff DL. Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. Plos One. 7: e29630. PMID 22253750 DOI: 10.1371/Journal.Pone.0029630  0.801
2012 Jahshan C, Cadenhead KS, Rissling AJ, Kirihara K, Braff DL, Light GA. Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychological Medicine. 42: 85-97. PMID 21740622 DOI: 10.1017/S0033291711001061  0.772
2012 Park S, Kim C, Braff D, Light G. Poster #72 RELATIONSHIP BETWEEN MMN AND FACIAL EMOTION RECOGNITION IN PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 136: S306. DOI: 10.1016/S0920-9964(12)70905-2  0.72
2011 Sun Y, Farzan F, Barr MS, Kirihara K, Fitzgerald PB, Light GA, Daskalakis ZJ. γ oscillations in schizophrenia: mechanisms and clinical significance. Brain Research. 1413: 98-114. PMID 21840506 DOI: 10.1016/J.Brainres.2011.06.065  0.447
2011 Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 168: 930-46. PMID 21498463 DOI: 10.1176/Appi.Ajp.2011.10050723  0.75
2011 Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, et al. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 128: 102-10. PMID 21288694 DOI: 10.1016/J.Schres.2011.01.005  0.781
2011 Mirzakhanian H, Jahshan C, Eyler LT, Light G, Cadenhead KS. Automatic sensory discrimination and emotion processing in prodromal and first-episode schizophrenia F1000research. 2. DOI: 10.7490/F1000Research.1463.1  0.534
2010 Rissling AJ, Light GA. Neurophysiological measures of sensory registration, stimulus discrimination, and selection in schizophrenia patients. Current Topics in Behavioral Neurosciences. 4: 283-309. PMID 21312404 DOI: 10.1007/7854_2010_59  0.584
2010 Rissling AJ, Makeig S, Braff DL, Light GA. Neurophysiologic markers of abnormal brain activity in schizophrenia. Current Psychiatry Reports. 12: 572-8. PMID 20857348 DOI: 10.1007/S11920-010-0149-Z  0.786
2010 Williams LE, Light GA, Braff DL, Ramachandran VS. Reduced multisensory integration in patients with schizophrenia on a target detection task. Neuropsychologia. 48: 3128-36. PMID 20600181 DOI: 10.1016/J.Neuropsychologia.2010.06.028  0.815
2010 Light GA, Williams LE, Minow F, Sprock J, Rissling A, Sharp R, Swerdlow NR, Braff DL. Electroencephalography (EEG) and event-related potentials (ERPs) with human participants. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 6.25.1-24. PMID 20578033 DOI: 10.1002/0471142301.Ns0625S52  0.724
2010 Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, et al. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophrenia Research. 119: 175-82. PMID 20382002 DOI: 10.1016/J.Schres.2010.03.004  0.782
2010 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, et al. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 47: 846-56. PMID 20374545 DOI: 10.1111/J.1469-8986.2010.01004.X  0.786
2010 Williams LE, Ramachandran VS, Hubbard EM, Braff DL, Light GA. Superior size-weight illusion performance in patients with schizophrenia: evidence for deficits in forward models. Schizophrenia Research. 121: 101-6. PMID 19931421 DOI: 10.1016/J.Schres.2009.10.021  0.782
2010 Jahchan C, Cadenhead K, Braff D, Light G. NEUROPHYSIOLOGICAL DEFICITS IN PRODROMAL AND RECENT-ONSET SCHIZOPHRENIA Schizophrenia Research. 117: 365-366. DOI: 10.1016/J.Schres.2010.02.647  0.824
2010 Light GA, Greenwood T, Sprock J, Swerdlow N, Braff D. Use of neurophysiological biomarkers for understanding the pathways from genes to real-world daily functioning in schizophrenia Neuroscience Research. 68: e49. DOI: 10.1016/J.Neures.2010.07.463  0.738
2009 Kiang M, Braff DL, Sprock J, Light GA. The relationship between preattentive sensory processing deficits and age in schizophrenia patients. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 120: 1949-57. PMID 19786365 DOI: 10.1016/J.Clinph.2009.08.019  0.779
2009 Young JW, Light GA, Marston HM, Sharp R, Geyer MA. The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. Plos One. 4: e4227. PMID 19156216 DOI: 10.1371/Journal.Pone.0004227  0.325
2009 Light G, Greenwood T, Rissling A, Pela M, Sprock J, Swerdlow N, Braff D. MMN is associated with genetic, clinical, cognitive, & functional abnormalities of schizophrenia Neuroscience Research. 65: S8. DOI: 10.1016/J.Neures.2009.09.1516  0.764
2008 Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, et al. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biological Psychiatry. 64: 1051-9. PMID 18701089 DOI: 10.1016/J.Biopsych.2008.06.018  0.784
2008 Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology. 199: 331-88. PMID 18568339 DOI: 10.1007/S00213-008-1072-4  0.781
2008 Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ. Advances in endophenotyping schizophrenia. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 7: 11-8. PMID 18458787 DOI: 10.1002/J.2051-5545.2008.Tb00140.X  0.792
2008 Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, et al. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 103: 218-28. PMID 18406578 DOI: 10.1016/J.Schres.2008.02.014  0.784
2008 Kiang M, Kutas M, Light GA, Braff DL. An event-related brain potential study of direct and indirect semantic priming in schizophrenia. The American Journal of Psychiatry. 165: 74-81. PMID 18056222 DOI: 10.1176/Appi.Ajp.2007.07050763  0.704
2008 Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ, Calkins ME, Gur RE, Gur RC, Turetsky BI, Dobie DJ, Radant AD, Tsuang DW, Freedman R, Olincy A, Cadenhead KS, et al. Advances in endophenotyping schizophrenia World Psychiatry. 7: 11-18.  0.768
2007 Light GA, Swerdlow NR, Braff DL. Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. Journal of Cognitive Neuroscience. 19: 1624-32. PMID 18271737 DOI: 10.1162/Jocn.2007.19.10.1624  0.663
2007 Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Archives of General Psychiatry. 64: 1242-50. PMID 17984393 DOI: 10.1001/Archpsyc.64.11.1242  0.771
2007 Möller B, Light GA, Fitzgerald PB, Snyder JS, Chen R, Daskalakis ZJ. Relationship between P50 suppression and the cortical silent period. Neuroreport. 18: 1503-6. PMID 17712283 DOI: 10.1097/Wnr.0B013E3282Ef6A29  0.391
2007 Wynn JK, Green MF, Sprock J, Light GA, Widmark C, Reist C, Erhart S, Marder SR, Mintz J, Braff DL. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophrenia Research. 95: 134-42. PMID 17662577 DOI: 10.1016/J.Schres.2007.05.039  0.772
2007 Kiang M, Light GA, Prugh J, Coulson S, Braff DL, Kutas M. Cognitive, neurophysiological, and functional correlates of proverb interpretation abnormalities in schizophrenia. Journal of the International Neuropsychological Society : Jins. 13: 653-63. PMID 17521483 DOI: 10.1017/S1355617707070816  0.78
2007 Kiang M, Kutas M, Light GA, Braff DL. Electrophysiological insights into conceptual disorganization in schizophrenia. Schizophrenia Research. 92: 225-36. PMID 17383161 DOI: 10.1016/J.Schres.2007.02.001  0.757
2007 Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, et al. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 92: 237-51. PMID 17346930 DOI: 10.1016/J.Schres.2007.01.012  0.703
2007 Braff DL, Light GA, Swerdlow NR. Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biological Psychiatry. 61: 1204-7. PMID 17161386 DOI: 10.1016/J.Biopsych.2006.08.015  0.747
2007 Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophrenia Bulletin. 33: 69-94. PMID 17135482 DOI: 10.1093/Schbul/Sbl060  0.634
2007 Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, et al. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophrenia Bulletin. 33: 33-48. PMID 17035358 DOI: 10.1093/Schbul/Sbl044  0.736
2007 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, et al. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophrenia Research. 89: 320-9. PMID 17023145 DOI: 10.1016/J.Schres.2006.08.010  0.768
2006 Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Archives of General Psychiatry. 63: 1325-35. PMID 17146007 DOI: 10.1001/Archpsyc.63.12.1325  0.765
2006 Light GA, Hsu JL, Hsieh MH, Meyer-Gomes K, Sprock J, Swerdlow NR, Braff DL. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biological Psychiatry. 60: 1231-40. PMID 16893524 DOI: 10.1016/J.Biopsych.2006.03.055  0.752
2006 Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 506-15. PMID 16123772 DOI: 10.1038/Sj.Npp.1300841  0.665
2005 Wynn JK, Light GA, Breitmeyer B, Nuechterlein KH, Green MF. Event-related gamma activity in schizophrenia patients during a visual backward-masking task. The American Journal of Psychiatry. 162: 2330-6. PMID 16330598 DOI: 10.1176/Appi.Ajp.162.12.2330  0.56
2005 Braff DL, Light GA. The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. Dialogues in Clinical Neuroscience. 7: 125-35. PMID 16262208  0.756
2005 Light GA, Braff DL. Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. The American Journal of Psychiatry. 162: 1741-3. PMID 16135637 DOI: 10.1176/Appi.Ajp.162.9.1741  0.778
2005 Erickson SK, Schwarzkopf SB, Palumbo D, Badgley-Fleeman J, Smirnow AM, Light GA. Efficacy and tolerability of low-dose donepezil in schizophrenia. Clinical Neuropharmacology. 28: 179-84. PMID 16062097 DOI: 10.1097/01.Wnf.0000173714.61744.E6  0.565
2005 Cadenhead KS, Light GA, Shafer KM, Braff DL. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biological Psychiatry. 57: 1504-9. PMID 15953486 DOI: 10.1016/J.Biopsych.2005.03.003  0.721
2005 Meincke U, Light GA, Geyer MA, Braff DL. On the waveform of the acoustic startle blink in the paradigm of prepulse inhibition - methodological and physiological aspects. Neuropsychobiology. 52: 24-7. PMID 15942260 DOI: 10.1159/000086174  0.614
2005 Braff DL, Light GA, Ellwanger J, Sprock J, Swerdlow NR. Female schizophrenia patients have prepulse inhibition deficits. Biological Psychiatry. 57: 817-20. PMID 15820241 DOI: 10.1016/J.Biopsych.2004.12.030  0.733
2005 Swerdlow NR, Stephany NL, Talledo J, Light G, Braff DL, Baeyens D, Auerbach PP. Prepulse inhibition of perceived stimulus intensity: paradigm assessment. Biological Psychology. 69: 133-47. PMID 15804542 DOI: 10.1016/J.Biopsycho.2004.07.002  0.63
2005 Light GA, Braff DL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Archives of General Psychiatry. 62: 127-36. PMID 15699289 DOI: 10.1001/Archpsyc.62.2.127  0.798
2004 Braff DL, Light GA. Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology. 174: 75-85. PMID 15118804 DOI: 10.1007/S00213-004-1848-0  0.777
2004 Meincke U, Light GA, Geyer MA, Braff DL, Gouzoulis-Mayfrank E. Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia. Psychiatry Research. 126: 51-61. PMID 15081627 DOI: 10.1016/J.Psychres.2004.01.003  0.788
2004 Light GA. Probing cortico-cortical interactions that underlie the multiple sensory, cognitive, and everyday functional deficits in schizophrenia Behavioral and Brain Sciences. 27: 799. DOI: 10.1017/S0140525X04340185  0.603
2003 Green MF, Mintz J, Salveson D, Nuechterlein KH, Breitmeyer B, Light GA, Braff DL. Visual masking as a probe for abnormal gamma range activity in schizophrenia. Biological Psychiatry. 53: 1113-9. PMID 12814862 DOI: 10.1016/S0006-3223(02)01813-9  0.739
2003 Light GA, Braff DL. Sensory gating deficits in schizophrenia: Can we parse the effects of medication, nicotine use, and changes in clinical status Clinical Neuroscience Research. 3: 47-54. DOI: 10.1016/S1566-2772(03)00018-5  0.785
2003 Light G, Ely M, Koev I, Sprock J, Goldman S, Braff D. Clinical and cognitive correlates of real-life functional deficits in schizophrenia patients Schizophrenia Research. 60: 143. DOI: 10.1016/S0920-9964(03)80954-4  0.565
2002 Cadenhead KS, Light GA, Geyer MA, McDowell JE, Braff DL. Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype? The American Journal of Psychiatry. 159: 869-71. PMID 11986147 DOI: 10.1176/Appi.Ajp.159.5.869  0.671
2001 Light GA, Braff DL. Measuring P50 suppression and prepulse inhibition in a single recording session. The American Journal of Psychiatry. 158: 2066-8. PMID 11729028 DOI: 10.1176/Appi.Ajp.158.12.2066  0.711
2001 Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophrenia Research. 49: 171-8. PMID 11343875 DOI: 10.1016/S0920-9964(00)00139-0  0.793
2000 Perry W, Light GA, Davis H, Braff DL. Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests. Schizophrenia Research. 46: 167-74. PMID 11120428 DOI: 10.1016/S0920-9964(99)00229-7  0.703
2000 Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. The American Journal of Psychiatry. 157: 767-71. PMID 10784470 DOI: 10.1176/Appi.Ajp.157.5.767  0.748
2000 Light GA, Braff DL. Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients? Biological Psychiatry. 47: 463-7. PMID 10704957 DOI: 10.1016/S0006-3223(99)00280-2  0.761
2000 Cadenhead KS, Light GA, Geyer MA, Braff DL. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. The American Journal of Psychiatry. 157: 55-9. PMID 10618013 DOI: 10.1176/Ajp.157.1.55  0.767
2000 Light G, Braff D. 139. Assessing prepulse inhibition and P50 suppression in a single test session Biological Psychiatry. 47: S42. DOI: 10.1016/S0006-3223(00)00401-7  0.656
2000 Cadenhead K, Shafer K, Light G, Perry W, Geyer M, Swerdlow N, Brenner C, McDowell J, Granholm E, Paulus M, Braff D. 117. Vulnerability markers in schizotypal personality disorder: defining a phenotype Biological Psychiatry. 47: S35-S36. DOI: 10.1016/S0006-3223(00)00379-6  0.581
1999 Light GA, Braff DL. Human and animal studies of schizophrenia-related gating deficits. Current Psychiatry Reports. 1: 31-40. PMID 11122903 DOI: 10.1007/S11920-999-0008-Y  0.809
1999 Light GA, Malaspina D, Geyer MA, Luber BM, Coleman EA, Sackeim HA, Braff DL. Amphetamine disrupts P50 suppression in normal subjects. Biological Psychiatry. 46: 990-6. PMID 10509182 DOI: 10.1016/S0006-3223(99)00034-7  0.694
1998 Freedman R, Adler LE, Nagamoto HT, Waldo MC, Braff DL, Light GA. Selection of digital filtering parameters and P50 amplitude Biological Psychiatry. 43: 921-922. PMID 9627749 DOI: 10.1016/S0006-3223(98)00119-X  0.526
1998 Light GA, Braff DL. The "incredible shrinking" P50 event-related potential. Biological Psychiatry. 43: 918-20. PMID 9627748 DOI: 10.1016/S0006-3223(98)00118-8  0.663
1998 Silverstein SM, Light G, Palumbo DR. The Sustained Attention Test: A Measure of Attentional Disturbance Computers in Human Behavior. 14: 463-475. DOI: 10.1016/S0747-5632(98)00017-X  0.339
1998 Light G, Malaspina D, Geyer M, Luber B, Sackeim H, Braff D. 294. P50 suppression in normal subjects after administration of amphetamine Biological Psychiatry. 43: S88-S89. DOI: 10.1016/S0006-3223(98)90742-9  0.609
1998 Light G, Braff D. 179. The “incredible shrinking” P50 event related potential Biological Psychiatry. 43: S53. DOI: 10.1016/S0006-3223(98)90627-8  0.543
1998 Cadenhead K, Light G, Geyer M, Braff D. 178. Psychophysiology in psychiatric research: Methodological issues Biological Psychiatry. 43: S53. DOI: 10.1016/S0006-3223(98)90626-6  0.582
1996 Light G, Geyer M, Clementz B, Schwarzkopf S, Braff D. Relationship between spectral characteristics of resting EEG and P50 gating Biological Psychiatry. 39: 656. DOI: 10.1016/0006-3223(96)84467-2  0.595
1995 Schwarzkopf S, Light G, Lamberti J, Silverstein S. Auditory ERPs in schizophrenia: Diagnostic and symptom correlates Biological Psychiatry. 37: 636. DOI: 10.1016/0006-3223(95)94565-E  0.367
Low-probability matches (unlikely to be authored by this person)
2018 Guillory S, Velthorst E, Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Addington J, Cadenhead K, Cannon T, Cornblatt B, et al. F202. Atypical P300 Amplitude Differentiates Conversion Patterns in Psychosis Prodrome When Autism Spectrum Disorder is Comorbid Biological Psychiatry. 83: S317-S318. DOI: 10.1016/J.Biopsych.2018.02.816  0.291
2017 Zhang W, Shiluk A, Rackelmann S, Tarasenko M, Thomas M, Bismark A, Joshi Y, Sprock J, Taylor A, Kauffman C, Cardoso L, Nisco A, Hsiao J, Swerdlow N, Light G. SU62. The 40-Hz Auditory Steady-State Response: A Sensitive and Predictive Biomarker of Perceptual Learning During Cognitive Training Schizophrenia Bulletin. 43: S183-S184. DOI: 10.1093/Schbul/Sbx024.060  0.287
2010 Breier MR, Lewis B, Shoemaker JM, Light GA, Swerdlow NR. Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats. Behavioural Brain Research. 208: 560-5. PMID 20080128 DOI: 10.1016/J.Bbr.2009.12.037  0.286
2023 Joshi YB, Gonzalez CE, Molina JL, MacDonald LR, Min Din J, Minhas J, Leposke T, Nordberg B, Li F, Talledo J, Sprock J, Swerdlow NR, Light GA. Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders. Psychiatry Research. 327: 115215. PMID 37406367 DOI: 10.1016/j.psychres.2023.115215  0.278
2017 Bhakta S, Light G, Talledo J, Balvaneda B, Hughes E, Alvarez A, Rana B, Young J, Swerdlow N. 777. Neural Targets of Tolcapone Enhanced Reverse-Translated 5-Choice Continuous Performance Test (5C-CPT) Performance in COMT-Genotyped Healthy Adults Biological Psychiatry. 81: S315-S316. DOI: 10.1016/J.Biopsych.2017.02.844  0.259
2015 Light GA, Swerdlow NR. Bending the curve on psychosis outcomes. The Lancet. Psychiatry. 2: 365-7. PMID 26360262 DOI: 10.1016/S2215-0366(15)00172-8  0.248
2022 Bhakta SG, Cavanagh JF, Talledo JA, Kotz JE, Benster L, Roberts BZ, Nungaray JA, Brigman JL, Light GA, Swerdlow NR, Young JW. EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35042948 DOI: 10.1038/s41386-021-01257-2  0.242
1999 Light GA, Zures J, Perry W. Repetition priming, recall and recognition in schizophrenic patients Archives of Clinical Neuropsychology. 14: 116-116. DOI: 10.1093/ARCLIN/14.1.116  0.209
2017 Pospos S, Young IT, Downs N, Iglewicz A, Depp C, Chen JY, Newton I, Lee K, Light GA, Zisook S. Web-Based Tools and Mobile Applications To Mitigate Burnout, Depression, and Suicidality Among Healthcare Students and Professionals: a Systematic Review. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association For Academic Psychiatry. PMID 29256033 DOI: 10.1007/S40596-017-0868-0  0.203
2017 Light G. 113. The “Other Side” of Translational Biomarker Development: Taking MMN from Academic Labs and into Real-World Settings to Predict and Monitor Response to Treatments Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.125  0.2
2019 Light GA, Swerdlow NR. Selection criteria for neurophysiologic biomarkers to accelerate the pace of CNS therapeutic development. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31506611 DOI: 10.1038/S41386-019-0519-0  0.197
2020 Treichler EBH, Cardoso L, Du Y, Nungaray J, Hochberger WC, Joshi YB, Sprock J, Cohen AN, Light GA. Contextualizing the road to recovery: A novel method of assessing outcome trajectories in clinical trials. Psychological Services. PMID 32658511 DOI: 10.1037/Ser0000432  0.194
2016 Light GA, Shiluk A, Zhang W, Rackelmann S, Bismark AW, Kauffman C, Hsiao JH, Thomas ML, Tarasenko M. The Other Side of Translational Biomarker Development: Taking MMN From Academic Labs to Real-World Community Treatment Centers International Journal of Psychophysiology. 108: 37. DOI: 10.1016/J.Ijpsycho.2016.07.124  0.184
2003 Schwarzkopf S, Badgley J, Light G, Fugle T, Guadagnino J, Williams C, Crilly J. State linked quantitative measures of symptomatology, cognition, and brain electrical activity in the clinical treatment of psychosis Schizophrenia Research. 60: 302-303. DOI: 10.1016/S0920-9964(03)80223-2  0.179
2020 Cadenhead KS, Duncan E, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bauchman P, Belger A, ... ... Light G, et al. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm Frontiers in Psychiatry. 11. DOI: 10.3389/fpsyt.2020.00833  0.178
2022 Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrión RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, et al. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis. Jama Psychiatry. PMID 35675082 DOI: 10.1001/jamapsychiatry.2022.1417  0.166
1994 Schwarzkopf S, Light G, Silverstein S, Smith D, Lamberti J, Hirt J. Physical versus social anhedonia in the measurement of psychosis proneness Biological Psychiatry. 35: 697. DOI: 10.1016/0006-3223(94)90951-2  0.159
2020 Roach BJ, Carrión RE, Hamilton HK, Bachman P, Belger A, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington J, Bearden CE, S Cadenhead K, Cannon TD, A Cornblatt B, McGlashan TH, et al. Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects study. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 131: 2899-2909. PMID 33160266 DOI: 10.1016/j.clinph.2020.09.027  0.149
2021 Swerdlow NR, Kotz JE, Joshi YB, Talledo J, Sprock J, Molina JL, Huisa B, Huege SF, Romero JA, Walsh MJ, Delano-Wood L, Light GA. Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration. Journal of Alzheimer's Disease : Jad. PMID 34690144 DOI: 10.3233/JAD-215029  0.136
2021 Cavanagh JF, Gregg D, Light GA, Olguin SL, Sharp RF, Bismark AW, Bhakta SG, Swerdlow NR, Brigman JL, Young JW. Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. Translational Psychiatry. 11: 482. PMID 34535625 DOI: 10.1038/s41398-021-01562-w  0.134
2021 Treichler EBH, Rabin BA, Spaulding WD, Thomas ML, Salyers MP, Granholm EL, Cohen AN, Light GA. Skills-based intervention to enhance collaborative decision-making: systematic adaptation and open trial protocol for veterans with psychosis. Pilot and Feasibility Studies. 7: 89. PMID 33781352 DOI: 10.1186/s40814-021-00820-4  0.134
2022 Cavanagh JF, Olguin SL, Talledo JA, Kotz JE, Roberts BZ, Nungaray JA, Sprock J, Gregg D, Bhakta SG, Light GA, Swerdlow NR, Young JW, Brigman JL. Amphetamine alters an EEG marker of reward processing in humans and mice. Psychopharmacology. PMID 35132440 DOI: 10.1007/s00213-022-06082-z  0.13
1995 Light G, Schwarzkopf S, Smith D, Boutros N. Stability of the acoustic startle reflex: Amplitude vs area measures Biological Psychiatry. 37: 618. DOI: 10.1016/0006-3223(95)94507-S  0.12
2022 Swerdlow NR, Joshi YB, Sprock J, Talledo J, Molina JL, Delano-Wood L, Iwanaga D, Kotz JE, Huege S, Leger G, Light GA. Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36404550 DOI: 10.3233/JAD-220769  0.115
2024 Noback M, Bhakta SG, Talledo JA, Kotz JE, Benster L, Roberts BZ, Nungaray JA, Light GA, Swerdlow NR, Brigman JL, Cavanagh JF, Young JW. Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker. Cognitive, Affective & Behavioral Neuroscience. PMID 38168850 DOI: 10.3758/s13415-023-01150-z  0.104
2021 Treichler EBH, Rabin BA, Cohen AN, Light GA. How Shared Is Shared Decision Making? Reaching the Full Potential of Patient-Clinician Collaboration in Mental Health. Harvard Review of Psychiatry. PMID 34352846 DOI: 10.1097/HRP.0000000000000304  0.077
1964 LIGHT GA. HISTORY, PHARMACOLOGY AND CLINICAL USE OF ETHYLENE. Clinical Anesthesia. 29: 135-50. PMID 14120105  0.074
2022 Treichler EBH, Mercado R, Oakes D, Perivoliotis D, Gallegos-Rodriguez Y, Sosa E, Cisneros E, Spaulding WD, Granholm E, Light GA, Rabin B. Using a stakeholder-engaged, iterative, and systematic approach to adapting collaborative decision skills training for implementation in VA psychosocial rehabilitation and recovery centers. Bmc Health Services Research. 22: 1543. PMID 36528579 DOI: 10.1186/s12913-022-08833-2  0.067
2023 Swerdlow NR, Gonzalez CE, Raza MU, Gautam D, Miyakoshi M, Clayson PE, Joshi YB, Molina JL, Talledo J, Thomas ML, Light GA, Sivarao DV. Effects of memantine on the auditory steady state and harmonic responses to 40 Hz stimulation across species. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 37683728 DOI: 10.1016/j.bpsc.2023.08.009  0.065
1957 LIGHT GA, MORCH ET, ENGEL R, CUNNINGHAM JJ. Promethazine (phenergan) hydrochloride as an adjunct to anesthesia; preliminary clinical and animal studies. Journal of the American Medical Association. 164: 1648-50. PMID 13448916 DOI: 10.1001/jama.1957.02980150016005  0.062
1965 LIGHT GA, RATTENBORG C, HOLADAY DA. A NEW VASOCONSTRICTOR: PRELIMINARY STUDIES OF PHELYPRESSIN. Anesthesia and Analgesia. 44: 280-7. PMID 14297319  0.052
1949 LIVINGSTONE HM, LIGHT GA. A record for the recovery room. Hospitals. 23: 60. PMID 18130600  0.052
2022 Nathan PJ, Millais SB, Godwood A, Dewit O, Cross DM, Liptrot J, Ruparelia B, Jones SP, Bakker G, Maruff PT, Light GA, Brown AJH, Weir MP, Congreve M, Tasker T. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 8: e12273. PMID 35229025 DOI: 10.1002/trc2.12273  0.049
1949 LIGHT GA, HAYMOND WV. Use of magnetic recorder silent music during operation. Current Researches in Anesthesia & Analgesia. 28: 330-8. PMID 15407043  0.044
1965 Light GA, Fini RA. Clinical impressions of the value of Darvon injectable. Anesthesia and Analgesia. 44: 722-5. PMID 5321190  0.033
2022 Cavanagh JF, Gregg D, Light GA, Olguin SL, Sharp RF, Bismark AW, Bhakta SG, Swerdlow NR, Brigman JL, Young JW. Correction to: Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. Translational Psychiatry. 12: 290. PMID 35864090 DOI: 10.1038/s41398-022-02070-1  0.031
1949 PETERS MP, BROBERG GR, LIGHT GA. Anesthesia for extremity amputations; a statistical review of 185 major amputation cases. American Journal of Surgery. 78: 220-5. PMID 18135637  0.029
1948 WEINSTEIN ML, LIGHT GA. Rectal sodium pentothal in 2,500 anesthesias. Current Researches in Anesthesia & Analgesia. 27: 343-50. PMID 18893457  0.025
1959 MOERCH ET, ENGEL R, LIGHT GA. Effects of pressure breathing on the peripheral circulation: motion picture observations in the bat wing and rabbit ear chamber. Archives of Surgery (Chicago, Ill. : 1960). 79: 493-6. PMID 14423191 DOI: 10.1001/archsurg.1959.04320090141021  0.024
1943 Weinstein ML, Light GA. Basal anesthesia with pentothal sodium.*: i. The use of pentothal sodium rectally as a basal anesthetic: Based on experience with 1,500 cases. Ii. Spinal anesthesia with rectal pentothal sodium basal narcosis Current Researches in Anesthesia and Analgesia. 22: 68-80.  0.021
1954 LIGHT GA, LOVE DM, BENSON D, MORCH ET. Music in surgery. Current Researches in Anesthesia & Analgesia. 33: 258-64. PMID 13182832  0.01
1950 LIGHT GA, LIVINGSTONE HM, ADAMS WE. Anesthesia for operations on the heart and great vessels. Archives of Surgery (Chicago, Ill. : 1920). 60: 42-54. PMID 15399391  0.01
1950 LIGHT GA, LIVINGSTONE HM, ADAMS WE. Resume of anesthetic experience in 1037 intrathoracic operations. Current Researches in Anesthesia & Analgesia. 29: 301-14. PMID 14783921  0.01
1940 Livingstone HM, Light GA, Heidrick AF, Kable VN. Further experience with divinyl ether (vinethene) anesthesia Journal of the American Medical Association. 115: 1353-1357. DOI: 10.1001/jama.1940.02810420039010  0.01
Hide low-probability matches.